SCHEMBL30721048

SCHEMBL30721048

Cc1cc(Br)c2nc(Cl)n(C3CC3)c(=O)c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.39
▸ PIK3CA P42336 6/20 0.39
▸ MAT2A P31153 1/20 0.36
▸ PRNP P04156 1/20 0.36
▸ PPARG P37231 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ NCOA2 Q15596 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ NR2E3 Q9Y5X4 1/20 0.36
▸ NCOR2 Q9Y618 1/20 0.36
▸ GAA P10253 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ F2RL3 Q96RI0 1/20 0.33
▸ DDR1 Q08345 3/20 0.32
▸ PLA2G1B P04054 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ ATG4B Q9Y4P1 1/20 0.32
▸ TOP2A P11388 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26957673 1.00 EGFR (0.39) EGFRPIK3CAMAT2APRNPPPARG
SCHEMBL30784552 0.95 GAA (0.38) EGFRPIK3CAMAT2APRNPPPARG
SCHEMBL30866157 0.91 PIK3CA (0.41) EGFRPIK3CADDR1
SCHEMBL30564404 0.84 EGFR (0.39) EGFRPIK3CAMAT2APRNPPPARG
SCHEMBL30866135 0.83 KMT2A (0.45) EGFRPIK3CAGAAALOX15HSD17B10
SCHEMBL30564366 0.79 SMN1; SMN2 (0.41) EGFRPIK3CAHTTNPSR1DDR1
SCHEMBL30564444 0.79 DDR1 (0.37) EGFRPIK3CAPRNPPPARGHTT
SCHEMBL25360881 0.79 EGFR (0.43) EGFRPRNPPPARGHTTNCOA2
SCHEMBL30336004 0.79 EGFR (0.43) EGFRPRNPPPARGHTTNCOA2
SCHEMBL15229032 0.78 ALOX15 (0.38) PIK3CAMAT2ANPSR1GAAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026424-A1 QUINAZOLINONE DERIVATIVES AS AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
WO-2024000401-A1 2-((1-(6-METHYL-4-OXO-3,4-DIHYDROQUINAZOLIN-8-YL)ETHYL)AMINO)BENZOIC ACID DERIVATIVES AND SIMILAR COMPOUNDS AS PI3K INHIBITORS FOR THE TREATMENT OF E.G. CANCER QILU REGOR THERAPEUTICS INC. (CN) 2024-01-04 — — WO disclosed
Send feedback